Ciencia en equipo e introducción acelerada de vacunas en Cuba: una mirada desde el Proyecto Neumococo
Linares-Pérez, Nivaldo.
Rev. cuba. salud pública
; 44(2)abr.-jun. 2018.
Artículo en Español | LILACS, CUMED | ID: biblio-901568
Documentos relacionados
Ciencia en equipo e introducción acelerada de vacunas en Cuba: una mirada desde el Proyecto Neumococo
Pneumococcal Surface Protein A: A Promising Candidate for the Next Generation of Pneumococcal Vaccines.
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
[Vaccination status and factors associated with pneumococcal vaccination in geriatric short-stay care].
Prevention of pneumococcal infections in childhood: two decades of progress.
Strengths and weaknesses of pneumococcal conjugate vaccines.
Efficacy of 13-valent pneumococcal conjugate vaccine in healthcare workers.
[Research progress of the surrogate of protection of pneumococcal conjugate vaccine].
Pneumonia vaccine response in individuals with Down syndrome at three specialty clinics.
A Randomized Controlled Clinical Trial of Nasal Immunization with Live Virulence Attenuated <i>Streptococcus pneumoniae</i> Strains Using Human Infection Challenge.